| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 196,681 | 215,572 | | Cost of Revenue | 82,108 | 95,978 | | | Gross Profit | 114,572 | 119,593 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 60,069 | 66,771 | | Non Recurring |
-
|
-
| | Others | 50,380 | 33,239 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 4,124 | 19,584 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,586) | 10,196 | | Earnings Before Interest And Taxes | (29,590) | 35,304 | | Interest Expense | 19,628 | 23,065 | | Income Before Tax | (49,218) | 12,239 | | Income Tax Expense | (11,494) | (8,081) | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (17,596) | 14,796 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (17,596) | 14,796 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($17,596) | $14,796 |
|
0.08% Nasdaq 
Income Statement
